期刊文献+

子宫内膜癌CerbB_2和P^(53)基因的表达及意义 被引量:3

A STUDY OF P^(53) and CerbB_2 EXPRESSIONS IN ENDEOMETRICAL CARCINOMA
下载PDF
导出
摘要 目的 探讨CerbB2 和P53 在子宫内膜癌中表达的意义和二者的关系。方法 应用免疫组织化学法回顾性分析了 85例子宫内膜癌患者的石蜡标本中CerbB2 和P53 蛋白的表达 ,并对其生存期进行随访。结果 CerbB2 和P53 表达的阳性率分别为 2 7.0 6 %、4 5 .88% ;CerbB2 阳性表达者的 5年生存率为 5 2 .38% ,阴性表达者为73.6 5 % ,差异有显著意义 (P <0 .0 5 ) ;P53 阳性表达者的 5年生存率 5 9.2 5 % ,阴性表达者为 84 .36 % ,差异有显著意义 (P <0 .0 5 ) ,CerbB2 和P53 表达间无相关性。结论 CerbB2 和P53 在子宫内膜癌中的表达与内膜癌的生物学行为有关 ,可作为子宫内膜癌预后的指标 。 Objective To investigate the clinical and pathological significances of CerbB_2 and P^(53) expressions in endometrical carcinoma and the relationship between them.Methods The expressions of CerbB_2 and P^(53) were (retrospectively) studied by immunohistochemical method.Their survival rate was surveyed in the following 5 years.Results The positive rates of P^(53) and CerbB_2 expressions were27.06% and 45.88% respectively. The five-year survival rates of the positive and negative cases were 52.38% and 73.65% respectively (P<0.01). The survival rates of cases of positive and negative P^(53) expressions were 59.25% and 84.36% respectively (P<0.05). No correlation was found between the expressions of CerbB_2 and P^(53).Conclusion P^(53) and CerbB_2 expressions in endometrical carcinoma have a close relationship to the degree of malignancy of endometrical carcinoma, contribute greatly to prognosis and can be used to instruct postoperative therapy.
出处 《临沂医学专科学校学报》 2004年第3期189-191,共3页 Journal of Linyi Medical College
关键词 子宫内膜癌 P53 CERBB2 Endometrical carcinoma P^(53) CerbB_2
  • 相关文献

参考文献8

  • 1[1]Hermanek P, Sobin LH. TNM classification of malignant tumors [M]. Fourth, fully revised edition. Spriger Verlag: UICC, international Union Against Cancer, 1987.40.
  • 2[2]Fajac A, Benard J, Lbomme C, et al. CerbB-2 gene amplification and protein expression in ovarian of their respective prognostic significance by multivariate analysis[J]. Int J cancer, 1995,64:146.
  • 3鲁永鲜,CzerwenkaK,HeussF.c-erbB2在增生性和恶性子宫内膜组织中的扩增与表达[J].中华妇产科杂志,1996,31(11):656-659. 被引量:7
  • 4薛凤霞,焦书竹,赵风喜,糜若然,朱元喜.子宫内膜癌p53抑癌基因蛋白表达及其与预后的关系[J].中华妇产科杂志,1995,30(11):647-650. 被引量:15
  • 5[5]Cherchi PL, Marras V, Capobianco G, et al. Prognostic value of P53 ,Cerb-B2 and MIB in endometrial carcinoma[J]. Eur J Gynaeocol Oncol,2001,22(6) :451-453.
  • 6[6]CoronadoPJ,VidartJA, Lopez-asenjoJA, etal. P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression[J]. Eur J Obstet Gynecol Reprod Biol, 2001,98(1): 103-108.
  • 7[7]Kohler MF, Berchuck A, Davidof F, et al. Overexpression and mutation of P53 in endometrial carcinoma[J]. Cancer Res, 1992,52:1662.
  • 8[8]Bur ME, Perlman C, Edelmann L, et al. P53 expression in neoplasms of the uterine corpus[J]. Am J Clin Pathol, 1992,98:81.

二级参考文献3

  • 1党进军,国外医学分子生物学分册,1991年,13卷,128页
  • 2唐素恩,中华妇产科杂志,1995年,1卷,3页
  • 3Wang D P,Virchows Arch,1992年,420卷,385页

共引文献18

同被引文献19

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部